Ridgefield, CT Director, Medical Clinical Evidence Implementation Liaison Respiratory Emerging Areas Unit

Job description

Language Custom Field 1 State City Custom Field 2 Custom Field 3 Custom Field 4 Location Clear Apply now » Director, Medical Clinical Evidence Implementation Liaison - Respiratory / Emerging Areas Description As an employee of Boehringer Ingelheim, you will actively contribute to the discovery, development and delivery of our products to our patients and customers. Our global presence provides opportunity for all employees to collaborate internationally, offering visibility and opportunity to directly contribute to the companies' success. We realize that our strength and competitive advantage lie with our people. We support our employees in a number of ways to foster a healthy working environment, meaningful work, mobility, networking and work-life balance. Our competitive compensation and benefit programs reflect Boehringer Ingelheim's high regard for our employees. The Director, Clinical Evidence Implementation Liaisons (CEILs), leads and develops a field-based team of Clinical Evidence Implementation Liaisons responsible for delivering focused medical engagement across prioritized therapeutic areas, assets, and organized customer accounts, including health systems, integrated delivery networks, payers, pharmacy benefit managers, and other organizations influencing population-based care. The Director translates approved TA and asset strategies into clear account priorities, portfolio decisions, and execution expectations; ensures CEILs build trusted scientific relationships, generate actionable account insights, and identify care-delivery, evidence-generation, quality-improvement, and Implementation Science opportunities with the potential for measurable patient and health-system impact. The role provides strategic and people leadership for the CEIL team by establishing consistent standards for account prioritization, scientific exchange, opportunity qualification, intervention execution, insight generation, and cross-functional collaboration. In partnership with CEIL leadership, TA/CDMA, the Implementation Science team, and relevant account partners, the Director evaluates emerging opportunities, governs deployment of team capacity and resources, supports execution of approved interventions, and escalates material portfolio or investment decisions through established governance. Through active field coaching, performance management, and continuous improvement, the Director builds team capability, reinforces compliant and ethical decision-making, and evolves the CEIL operating model in response to changing healthcare-system needs while maintaining alignment with Medicine strategy. Duties & Responsibilities CEIL Strategy, Portfolio Prioritization, and Resource Leadership Translate approved Medicine, TA, and asset strategies into a clear CEIL engagement strategy, operating priorities, and execution expectations across assigned health-system and payer segments. Establish and apply consistent criteria for account prioritization, account assignment, stakeholder focus, and deployment of team capacity. Review emerging opportunities and changing account conditions; make evidence-based recommendations to continue, expand, modify, replace, or deprioritize account activity, while escalating material investment decisions through established governance. Scientific Engagement and Account Medical Leadership Set standards and provide oversight for high-quality, compliant scientific exchange and account medical leadership across prioritized organized customers. Ensure Clinical Evidence Implementation Liaisons develop trusted relationships with relevant scientific, clinical, quality, pharmacy, informatics, care-coordination, and executive stakeholders; understand account decision-making and evidence needs; and contribute appropriately to integrated account planning. Resolve role-boundary or coordination issues and strengthen collaboration across CEIL, TA/CDMA, MSL, market access, account, and other relevant partners. Care-Gap, Patient-Journey, and Implementation Science Opportunity Leadership Build team capability and establish a consistent approach for identifying and characterizing account-level barriers across the patient journey, including workflow, stakeholder alignment, readiness, data availability, and capacity for change. Review and challenge opportunity assessments and briefs to ensure they are evidence based and aligned with approved TA priorities. In partnership with the Medical implementation Science team and TA/CDMA leadership, govern the qualification, prioritization, and advancement of opportunities for evidence generation, quality improvement, healthcare transformation, or Implementation Science collaboration. Approved Intervention and Pilot Execution Oversight Provide leadership oversight for CEIL participation in approved Implementation Science, quality-improvement, evidence-generation, and healthcare-transformation interventions. Clarify accountability, decision rights, and escalation pathways; ensure appropriate stakeholder alignment, onboarding, workflow integration, monitoring, and issue resolution; and confirm execution remains within approved scientific, compliance, governance, and measurement parameters. Use implementation learning to strengthen subsequent account selection, intervention design, and field execution. Insight Generation, Synthesis, and Organizational Learning Establish expectations and quality standards for the identification, documentation, synthesis, and communication of actionable account insights. Integrate themes across customers and therapeutic areas to identify healthcare-system trends, evidence needs, patient-journey barriers, market developments, and scalable opportunities. Ensure insights reach the appropriate Medicine, TA/CDMA, and account stakeholders and are translated into clear implications for strategy, planning, evidence generation, and execution. Compensation The base salary range for this position is $230,400 to $345,600. The position may be eligible for a role specific discretionary bonus, relocation, and/or other compensation elements. We continuously review market data and may adjust salary ranges as needed in the future. Actual compensation will be based on job-related factors such as skills, experience, and qualifications, and other factors permitted by law. Benefits include medical, dental and vision coverage, retirement savings opportunities, paid time off, paid holidays, disability and life insurance benefits, and other company-sponsored programs. For additional information regarding our benefits and Total Rewards offerings, please click here. Requirements Master's degree in a scientific discipline required (e. g., MSc.) with a minimum of 10 years in the pharmaceutical/healthcare industry, of which 7 years are in a customer-facing role or in a management / market access role is required. Doctoral degree preferred (e. g., PharmD, PhD, MD, DO). Field Medical Leadership: Demonstrated success leading geographically dispersed, customer-facing medical teams, setting clear direction and standards, translating strategy into execution, and delivering results through others. People and Talent Leadership: Proven ability to select, onboard, coach, develop, engage, and retain talent; differentiate performance; address capability or performance gaps; foster accountability; and build succession and leadership capability. Strategic and Portfolio Leadership: Ability to translate Medicine, TA, and asset strategies into account priorities, portfolio choices, resource-allocation decisions, execution standards, and measures of medical impact across complex organized-customer segments. Scientific and Healthcare-System Acumen: Strong scientific credibility and understanding of the U.S. healthcare ecosystem, including health systems, integrated delivery networks, accountable care organizations, payers, pharmacy benefit managers, Medicare, Medicaid, and population-health decision-making. Account Engagement and Scientific E